DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / S••••• V••••••••• P•••••••
P••••••••• C•••••• P••••••• Announces Investment in S••••• V••••••••• P•••••••
Type not statedclosedannounced Apr 14, 2020closed Apr 14, 2020Fact
What happened
- Platform
- not an add-on on record
- Control
- unknown
- Share acquired
- unknown
- Industry
- healthcare / pharma, veterinar
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
2 named
Buy side
- “P••••••••• C•••••• P••••••• ( "PCP" ), a private equity fund focused exclusively on investing in high-growth opportunities in Canadian healthcare, is pleased to announce that it has made an investment in S••••• V••••••••• P••••••• ( “S•••••” ), Canada’s leading veterinary compounding pharmacy.”
Side not stated
- “P••••••••• C•••••• P••••••• ( "PCP" ), a private equity fund focused exclusively on investing in high-growth opportunities in Canadian healthcare, is pleased to announce that it has made an investment in S••••• V••••••••• P••••••• ( “S•••••” ), Canada’s leading veterinary compounding pharmacy.”
Evidence
“P••••••••• C•••••• P••••••• ( "PCP" ), a private equity fund focused exclusively on investing in high-growth opportunities in Canadian healthcare, is pleased to announce that it has made an investment in S••••• V••••••••• P••••••• ( “S•••••” ), Canada’s leading veterinary compounding pharmacy.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026